Details for 2016742444
Up to date per 02.04.2026
Actions
Details for 2016742444
Deleted
European Patent
25.04.2018 A
05.08.2020 B1
18.06.2015
US
201562181602 P
C12N 15/113 20100101AFI20170105BHEP
Owner
Alnylam Pharmaceuticals, Inc.300 Third Street, 3rd Floor Cambridge, MA 02142US
Representative
No representatives present
Inventor
HINKLE, Gregory300 Third Street 3rd Floor Cambridge, MA 02142US